Before using any compounded semaglutide, visually inspect the medication
GLP-1 and GLP-1 receptor agonists decrease food intake and cause weight loss (65, 66)
After assessing the literature, we divided medications into one of three groups: medications that should be avoided in individuals with G6PD deficiency, medications that were considered unsafe by at least one source, but according to our review can probably be given safely in normal therapeutic dosages to individuals with G6PD deficiency as evidence does not contravene their use, and medications where no evidence at all was found to contravene their use in G6PD-deficient patients
And then there are the hidden changes: hormones, brain chemicals, and blood sugar levels
The FDA label includes a boxed warning regarding the risk of thyroid C-cell tumors observed in rodent studies
Compounded medications are not FDA-approved and may carry different risks than FDA-approved medications